Co-Authors
This is a "connection" page, showing publications co-authored by Kenneth Remy and Richard Hotchkiss.
Connection Strength
2.108
-
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020 09 03; 5(17).
Score: 0.901
-
Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report. Crit Care Explor. 2021 Jul; 3(7):e0500.
Score: 0.239
-
In Vitro-Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019. Crit Care Explor. 2021 Apr; 3(4):e0378.
Score: 0.234
-
Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor. 2021 Mar; 3(3):e0374.
Score: 0.233
-
Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020 07 01; 3(7):e2016485.
Score: 0.223
-
Immunotherapies for COVID-19: lessons learned from sepsis. Lancet Respir Med. 2020 10; 8(10):946-949.
Score: 0.220
-
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020 12; 6(50).
Score: 0.057